Skip to main content

Advertisement

Log in

Approach and Work-Up for Medical Pruritus

  • Review
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Medical pruritus is characterized by itch secondary to systemic causes, which typically presents in the absence of primary skin lesions. Distinguishing medical pruritus from primary dermatologic pruritus on skin examination is challenging, given that some forms of dermatologic pruritus have very few or no primary lesions, or the primary lesions are obscured by secondary lesions. As a consequence of such diagnostic challenge, pruritus presentation often remains “idiopathic.” Unfortunately, underlying systemic diagnoses may be associated with significant morbidity and mortality, such as lymphoproliferative diseases or HIV infection. This highlights the importance of developing a systematic approach to patients presenting with medical pruritus. Therefore, patients presenting with generalized pruritus without primary skin lesions should be evaluated for systemic disorders through detailed patient history and physical examination, which could guide further laboratory investigations. If an underlying cause of pruritus is not identified, patients should be re-evaluated periodically with a review of systems and physical examination. The aim of this review is to discuss systemic causes of itch and propose a practical, evidence-based approach to the work-up of medical pruritus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011;1(3):177–84.

    Google Scholar 

  2. Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol. 2010;49(1):1–11.

    CAS  Google Scholar 

  3. Kremer AE, Bolier R, van Dijk R, Oude Elferink RP, Beuers U. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis. 2014;32(5):637–45.

    Google Scholar 

  4. Beard MP, Millington GW. Recent developments in the specific dermatoses of pregnancy. Clin Exp Dermatol. 2012;37(1):1–4 (quiz 5).

    CAS  Google Scholar 

  5. Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis. 2012;16(2):331–46.

    Google Scholar 

  6. Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management. Dermatol Clin. 2002;20(3):459–72 (vi-vii).

    Google Scholar 

  7. Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35(2):636–41.

    Google Scholar 

  8. Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch Dermatol. 1974;109(5):678–81.

    CAS  Google Scholar 

  9. Murphy GM, Ross A, Billing BH. Serum bile acids in primary biliary cirrhosis. Gut. 1972;13(3):201–6.

    CAS  Google Scholar 

  10. Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol. 1987;82(2):117–8.

    CAS  Google Scholar 

  11. Summerfield JA. Naloxone modulates the perception of itch in man. Br J Clin Pharmacol. 1980;10(2):180–3.

    CAS  Google Scholar 

  12. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ. 1988;297(6662):1501–4.

    CAS  Google Scholar 

  13. Eisendle K, Muller H, Ortner E, Talasz H, Graziadei I, Vogel W, et al. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol. 2011;26(4):716–21.

    CAS  Google Scholar 

  14. Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990;34(3):136–41.

    CAS  Google Scholar 

  15. Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant. 1995;10(12):2174–6.

    CAS  Google Scholar 

  16. Stahle-Backdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh). 1989;145:1–38.

    CAS  Google Scholar 

  17. Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11–20.

    Google Scholar 

  18. Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.

    Google Scholar 

  19. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus–new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002;17(9):1558–63.

    Google Scholar 

  20. Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med. 1979;91(1):17–21.

    CAS  Google Scholar 

  21. Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19(7):1895–901.

    CAS  Google Scholar 

  22. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron. 1994;67(3):270–3.

    CAS  Google Scholar 

  23. Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, et al. Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol. 2012;36(2):175–83.

    CAS  Google Scholar 

  24. Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49(5):842–6.

    Google Scholar 

  25. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4(1):72–7.

    CAS  Google Scholar 

  26. Masmoudi A, Hajjaji Darouiche M, Ben Salah H, Ben Hmida M, Turki H. Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patients. J Dermatol Case Rep. 2014;8(4):86–94.

    Google Scholar 

  27. Isaacs NJ, Ertel NH. Urticaria and pruritus: uncommon manifestations of hyperthyroidism. J Allergy Clin Immunol. 1971;48(2):73–81.

    CAS  Google Scholar 

  28. Graham DT, Goodell H, Wolff HG. Studies on pain: the relation between cutaneous vasodilatation, pain threshold and spontaneous itching and pain. Am J Med Sci. 1957;234(4):420–30.

    CAS  Google Scholar 

  29. Lewiecki EM, Rahman F. Pruritus. A manifestation of iron deficiency. JAMA. 1976;236(20):2319–20.

    CAS  Google Scholar 

  30. Valsecchi R, Cainelli T. Generalized pruritus: a manifestation of iron deficiency. Arch Dermatol. 1983;119(8):630.

    CAS  Google Scholar 

  31. Sato S. Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol. 1991;10(4):313–9.

    CAS  Google Scholar 

  32. Kluger N, Raison-Peyron N, Rigole H, Bessis D, Blanc F, Guillot B. Generalized pruritus revealing hereditary haemochromatosis. Acta Derm Venereol. 2007;87(3):277.

    Google Scholar 

  33. Polat M, Oztas P, Ilhan MN, Yalcin B, Alli N. Generalized pruritus: a prospective study concerning etiology. Am J Clin Dermatol. 2008;9(1):39–44.

    Google Scholar 

  34. Krajnik M, Zylicz Z. Pruritus in advanced internal diseases Pathogenesis and treatment. Neth J Med. 2001;58(1):27–40.

    CAS  Google Scholar 

  35. Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther. 2010;23(6):590–6.

    Google Scholar 

  36. Pavlidis NA, Klouvas G, Tsokos M, Bai M, Moutsopoulos HM. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders–a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma. 1995;16(5–6):477–82.

    CAS  Google Scholar 

  37. Diehn F, Tefferi A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115(3):619.

    CAS  Google Scholar 

  38. Siegel FP, Tauscher J, Petrides PE. Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients. Am J Hematol. 2013;88(8):665–9.

    Google Scholar 

  39. Blanes M, Belinchon I, Portilla J, Betlloch I, Reus S, Sanchez-Paya J. Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: a study of its prevalence and causes. Int J STD AIDS. 2012;23(4):255–7.

    CAS  Google Scholar 

  40. Lee HG, Stull C, Yosipovitch G. Psychiatric disorders and pruritus. Clin Dermatol. 2017;35(3):273–80.

    Google Scholar 

  41. Rowe B, Yosipovitch G. Malignancy-associated pruritus. Eur J Pain. 2016;20(1):19–23.

    CAS  Google Scholar 

  42. Bakker CV, Terra JB, Pas HH, Jonkman MF. Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol. 2013;149(8):950–3. https://doi.org/10.1001/jamadermatol.2013.756.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors were involved in the development, research, writing, and editing of this manuscript.

Corresponding author

Correspondence to Amanda Shelley.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

- Given the morbidity and mortality associated with underlying systemic causes of medical pruritis, it is important to develop an evidence-based approach to patients presenting with generalized itch.

- Most common diagnoses to consider in patients with medical pruritis include cholestatic pruritus, chronic kidney disease-associated pruritus, hyperthyroidism, iron disorders, lymphoproliferative disorders, myeloproliferative disorders, and HIV infection.

- Detailed patient history, physical examination, and laboratory investigations are required to diagnose the underlying systemic cause of medical pruritis.

This article is part of the Topical Collection on Medicine.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haxho, F., Shelley, A., Lytvyn, Y. et al. Approach and Work-Up for Medical Pruritus. SN Compr. Clin. Med. 4, 236 (2022). https://doi.org/10.1007/s42399-022-01313-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s42399-022-01313-y

Keywords

Navigation